Clinical operations and revenue cycle
Regard
AI clinical insights platform that surfaces patient history context and documentation before physician review.
Last updated: June 5, 2026
Back to directoryBiobeat Cuffless Blood Pressure Monitoring medical AI product profile
Wearable monitoring platform using a chest patch and cloud dashboard for cuffless blood-pressure monitoring and other clinician-reviewed physiologic signals.
Clinical operations and revenue cycle
Best fit
Programs that need FDA-cleared cuffless blood-pressure monitoring or supervised remote physiologic data collection with explicit calibration, reporting, and review workflows.
- Primary use case
- Cuffless ambulatory blood pressure monitoring, wearable vital-sign collection, remote physiologic monitoring, early-warning review, hypertension assessment, and clinician-reviewed patient reports
- Audience
- Cardiology practices, hypertension clinics, remote patient monitoring programs, hospital-at-home teams, long-term care programs, and virtual care operations leaders
- Risk level
- Medium to high
- Pricing signal
- Commercial device and platform pricing varies by monitoring workflow, device model, program size, service terms, and region; request current Biobeat terms.
- Official sources
- 7 official sources
Compare within workflow: Clinical operations and revenue cycle · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Biobeat Cuffless Blood Pressure Monitoring as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Match each deployment to the exact FDA-cleared device, 510(k) number, measured parameter, intended setting, adult population, calibration requirement, and non-critical-care limitation before using outputs in care workflows. |
|---|---|
| Privacy | Review Biobeat's privacy policy and enterprise contract for device data, mobile app data, dashboard access, tokenization, controller versus processor roles, anonymized analytics, geolocation connectivity data, retention, support access, and cross-border transfer controls. |
| Evidence | Validate cuffless blood-pressure and physiologic-signal performance against the local patient population, calibration process, wear time, skin and motion artifacts, home connectivity, report quality, and escalation outcomes. |
| Workflow | Best governed as clinician-reviewed remote physiologic monitoring with clear onboarding, calibration, patient instructions, report review, escalation, device troubleshooting, downtime, and removal-from-monitoring criteria. |
Where Biobeat Cuffless Blood Pressure Monitoring fits
Biobeat describes cuffless 24-hour blood pressure monitoring with a wireless, non-invasive chest patch and lists multiple FDA 510(k) numbers; FDA records list K241066 for BB-613-BPM and K222010 for Biobeat Platform-2, with Platform-2 intended for healthcare-professional spot-checking and tracking of adult patients in hospitals, clinics, long-term care, and at home, and not intended for critical-care patients.
Not for: Critical-care monitoring, emergency response without staffed escalation, uncalibrated blood-pressure interpretation, autonomous diagnosis, or replacing clinician review of generated reports.
What to verify before using Biobeat Cuffless Blood Pressure Monitoring
- Which Biobeat device and workflow are in scope, including BB-613-BPM, Biobeat Platform-2, chest patch, wrist device, 24-hour ABPM, RPM, hospital, clinic, long-term care, or home use.
- Current FDA 510(k) records, intended-use wording, adult-patient limits, calibration requirements, monitored parameters, and whether alarms or critical-care monitoring are excluded.
- How raw signals, mobile app data, reports, dashboards, alerts, device IDs, geolocation, support access, retention, tokenization, anonymization, and enterprise-client controller or processor roles are handled.
- Local validation for cuffless blood-pressure accuracy, calibration workflow, adherence, artifact handling, report turnaround, false escalation, missed deterioration, clinician workload, and patient-safety events.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.bio-beat.com
- www.bio-beat.com / bpm
- www.bio-beat.com / solutions / in-hospital-monitoring
- www.accessdata.fda.gov / scripts / cdrh
- www.accessdata.fda.gov / scripts / cdrh
- www.accessdata.fda.gov / cdrh_docs / pdf22
- www.bio-beat.com / privacy-policy
Related medical AI products
Clinical operations and revenue cycle
Bayesian Health
Real-time clinical intelligence platform with an FDA-cleared continuous sepsis flagging device and broader inpatient risk workflow modules.
Clinical operations and revenue cycle
CLEW ICU
FDA-cleared clinical surveillance platform that uses machine-learning models to surface adult ICU deterioration risk and workflow notifications.
Clinical operations and revenue cycle
Mednition KATE
Clinical AI platform for emergency departments that uses EHR data and clinical NLP to support nurse triage, sepsis-risk recognition, and operational analytics.